Quibim’s technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startup’s customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.
The path to a sustainable HaH program looks different for regional systems. A smaller, more focused program, designed around their unique needs, can deliver strong clinical and operational value. The post How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems? appeared first on MedCity News.
During FHIR survey webinar, HL7 says it is working on FHIR accelerators around medical devices, quality measures
By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive. The post How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergencies appeared first on MedCity News.
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
The current system is failing vulnerable patients – those it was designed to help. While well-intentioned, the savings these programs promise rarely trickle down to patients. The post The Dysfunctional Drug Discount System’s Serious Implications on Patient Health appeared first on MedCity News.
The Trump administration took another step Tuesday to weaken protections for Americans with medical debt, issuing new guidance that threatens ongoing state efforts to keep that debt off consumers’ credit reports. More than a dozen states, including Washington, Oregon, California, Colorado, Minnesota, Maryland, New York, and most of New England, have enacted laws in recent…
AI is no panacea, but it can have a role in turning artisanal, trial-and-error drug development into a rapid, cost-effective, data-driven process. The post AI Meets Gene Editing: the Path to Plug-and-Play Drug Development appeared first on MedCity News.
Dr. Shantanu Nundy describes how care navigation company Accolade can help self-insured employers lower costs for providing health coverage to their employees. The post MedCity Pivot: A Chat with Accolade’s Chief Health Officer appeared first on MedCity News.
This edition looks at how political rhetoric is driving misinformation about fentanyl and immigration, legal implications of fentanyl-laced counterfeit pills sold on social media, and myths about opioid exposure.